Table 1.
Relationship between circBACH2 expression and clinical-pathological features of TNBC patients (n = 38).
| Variables | Cases (n = 38) | circBACH2 | P value | |
|---|---|---|---|---|
| Low (n = 19) | High (n = 19) | |||
| Age (years) | ||||
| <50 | 9 | 7 (77.8%) | 2 (22.2%) | 0.125 |
| ≥50 | 29 | 12 (41.4%) | 17 (58.6%) | |
| Menopause | ||||
| No | 15 | 6 (40.0%) | 9 (60.0%) | 0.508 |
| Yes | 23 | 13 (56.5%) | 10 (43.5%) | |
| T stage | ||||
| T1–T2 | 16 | 12 (75.0%) | 4 (25.0%) | 0.020 |
| T3–T4 | 22 | 7 (31.8%) | 15 (68.1%) | |
| N stage | ||||
| N0 | 18 | 14 (77.8%) | 4 (22.2%) | 0.003 |
| N1–3 | 20 | 5 (25.0%) | 15 (75.0%) | |
| TNM stage | ||||
| I–II | 17 | 15 (88.2%) | 2 (11.8%) | <0.001 |
| III–IV | 21 | 4 (19.1%) | 17 (81.0%) | |
TNBC triple-negative breast cancer, TNM tumor-node-metastasis.
A value of P < 0.05 was considered statistically significant.